Corrigendum: Chloroquine Inhibits Stemness of Esophageal Squamous Cell Carcinoma Cells Through Targeting CXCR4-STAT3 Pathway

Front Oncol. 2022 Feb 24:12:860158. doi: 10.3389/fonc.2022.860158. eCollection 2022.

Dongli Yue^{1

2}, Daiqun Zhang¹, Xiaojuan Shi¹, Shasha Liu¹, Anqi Li¹, Dong Wang^{1

2}, Guohui Qin^{1

2}, Yu Ping¹, Yamin Qiao^{1

2}, Xinfeng Chen^{1

2}, Feng Wang², Renyin Chen³, Song Zhao⁴, Lidong Wang⁵, Yi Zhang^{1

6

7}

¹ Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
² Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
³ Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
⁴ Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
⁵ Henan Key Laboratory for Esophageal Cancer Research and State Key Laboratory for Esophageal Cancer Prevention & Treatment of The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
⁶ School of Life Sciences, Zhengzhou University, Zhengzhou, China.
⁷ Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, China.

Abstract

[This corrects the article DOI: 10.3389/fonc.2020.00311.].

Keywords: CXCR4; STAT3; cancer stem cells (CSCs); chloroquine (CQ); esophageal squamous cell carcinoma (ESCC).